|For immediate use||
Aug. 11, 2006 -- No. 369
Study reveals how cells destroy faulty proteins in cystic fibrosis
CHAPEL HILL - The cellular system that degrades faulty proteins created by
the cystic fibrosis gene has been identified by University of North Carolina
at Chapel Hill scientists. Turning off the degradation system allows some proteins
to regain their proper shape, offering a new avenue for treatments aimed at
curing the disease.
Cystic fibrosis (CF) is a fatal disease caused by a defective gene that produces a misshapen form of the protein cystic fibrosis transmembrane conductance regulator (CFTR). People with cystic fibrosis do not have enough CFTR for their cells to work normally because their bodies quickly destroy the mutant protein.
"Most cases of CF are caused by the inability of faulty CFTR to get in the correct shape, which leads cells to place it in the trash bin," said senior author Dr. Douglas Cyr, professor of cell and developmental biology at UNC School of Medicine. "Our research helps define the basic mechanism for CF and identify targets for the development of therapeutics designed to get CFTR into shape and allow it function normally in the lung."
The results, published Aug. 11, 2006, in the journal Cell, point to several possible targets for the development of new treatments aimed at stopping the disease, the researchers said.
Scientists have known for some time that treatment of cultured cells with compounds known as chemical chaperones can increase the fitness of misshaped CFTR and get it into proper shape. "If we can figure out how to get CFTR into the right shape, we can cure the disease," Cyr said.
To better understand how to fix CFTR, Cyr's research team at the UNC Cystic Fibrosis Center focused on identifying the cellular system that disposes of faulty CFTR. Investigators identified cell components that specifically recognize misshapen CFTR and drop it in the molecular trash bin. The team found that turning off these components - the cell's trash collectors - extends the life of faulty CFTR proteins and thereby enables some of it to assume a functional shape.
The trash collectors newly identified by the UNC team are two ubiquitin ligases, proteins that recognize misshaped regions of CFTR and tag them with a degradation signal know as ubiquitin. The ubiquitin tag tells the cell to destroy the marked CFTR, a process overseen by a destroyer called the proteasome. This trash system is known as the ubiquitin proteasome pathway.
"We've identified the trash collectors that recognize misfolded proteins, decide if they might be toxic to the cell and mark them with ubiquitin. The ubiquitinated proteins, including faulty CFTR, are then degraded or shredded by the proteasome," Cyr said.
"Understanding this pathway gives us greater insight into what's wrong with the protein - information that will help people design better therapeutics for the disease."
Study co-authors, all of the UNC Cystic Fibrosis Pulmonary Research and Treatment Center, include J. Michael Younger, graduate student and first author; postdoctoral researchers Drs. Liling Chen, Meredith F.N. Rosser, Emma L. Turnbull and Chung-Yan Fan; Hong-Yu Ren, technician; and Dr. Cam Patterson, professor of medicine, cardiology division chief and director of the Carolina Cardiovascular Biology Center.
The UNC Cystic Fibrosis Pulmonary Research and Treatment Center is a multidisciplinary group focused on the pathogenesis and therapy of cystic fibrosis and other lung diseases. It has one of the largest clinical programs in the country, with more than 500 patients in pediatric and adult programs.
The study was funded by the National Institute of General Medical Sciences, part of the National Institutes of Health, the Cystic Fibrosis Foundation and the American Heart Association.
UNC School of Medicine contacts: Les Lang, 919-843-9687, firstname.lastname@example.org;
Dr. Douglas Cyr, email@example.com
News Services contact: Becky Oskin, 919-962-8596, firstname.lastname@example.org